Let’s talk AI: Top R&D execs tackle where we are and where we’re headed with this crucial new technology

As a biotech exec with a background in computational chemistry, Rosana Kapeller has been watching the hubbub over artificial intelligence and machine learning in biopharma play out with a considerable degree of skepticism.

“People talk about ML and AI without knowing what they are talking about,” the outspoken Nimbus alum told me earlier in the week.